Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
Característiques principals
This Call is being run in a two stage submission and evaluation process.
Short proposals for this call can only be done through the IMI SOFIA software tool:
https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx
Característiques principals
Topics of the 9th Call:
  • Addressing the clinical burden of Clostridium difficile infection (CDI): Evaluation of the burden, current practices and set-up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
  • Development of immune tolerance therapies for the treatment of rheumatic diseases
  • Data quality in preclinical research and development
  • Next generation of electronic translational safety
  • Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)
  • Joint influenza vaccine effectiveness studies
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://www.imi.europa.eu/content/imi-2-call-9
    Dotació
    IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities, while the other entities (including the EFPIA companies) participate in the project with their own resources.
    The EU contribution is:
  • Topic 1: 3 000 000 EUR
  • Topic 2: 6 000 000 EUR
  • Topic 3: 4 500 000 EUR
  • Topic 4: 20 000 000 EUR
  • Topic 5: 15 828 000 EUR
  • Topic 6: 9 000 000 EUR
    • AVÍS IMPORTANT
    During April, IMI held webinars on all IMI 2 – Call 9 topics as well as IMI’s rules and procedures. The presentations from, and recordings of, all IMI 2 – Call 9 webinars can be found on the webinar page: http://www.imi.europa.eu/events/2016/03/18/webinars-imi2-call-9

    Arxius

    Arxiu
    Call text
    Manual for Submission and evaluation